Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide + Insulin in Japanese T2DM
NCT01572740Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 2012
- Primary completion
- Nov 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Apr 2012; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01572740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01572740.